α-Ethyltryptamine

α-Ethyltryptamine
Clinical data
Other names	alpha-Ethyltryptamine; αET; AET; Etryptamine; 3-(2-Aminobutyl)indole; 3-Indolylbutylamine; Ro 3-1932; NSC-88061
ATC code	none;
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); CA: Schedule III; DE: Anlage I (Authorized scientific use only); UK: Class A; US: Schedule I; UN: Psychotropic Schedule I;
Identifiers
	IUPAC name 1-(1H-indol-3-yl)butan-2-amine;
CAS Number	2235-90-7 118-68-3;
PubChem CID	8367;
PubChem SID	46507084;
DrugBank	DB01546 ;
ChemSpider	8064 ;
UNII	GR181O3R32;
KEGG	D04092;
ChEBI	CHEBI:134838;
ChEMBL	ChEMBL1619758;
CompTox Dashboard (EPA)	DTXSID1046764 ;
Chemical and physical data
Formula	C12H16N2
Molar mass	188.274 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	222 to 223 °C (432 to 433 °F)
	SMILES CCC(N)CC1=CNC2=CC=CC=C12;
	InChI InChI=1S/C12H16N2/c1-2-10(13)7-9-8-14-12-6-4-3-5-11(9)12/h3-6,8,10,14H,2,7,13H2,1H3 ; Key:ZXUMUPVQYAFTLF-UHFFFAOYSA-N ;
	(verify)

α-Ethyltryptamine (αET, AET), also known as etryptamine (INN, BAN, USAN), is a psychedelic, stimulant, and entactogenic drug of the tryptamine class. It was originally developed and marketed as an antidepressant under the brand name Monase by Upjohn in the 1960s.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.